Baxalta Innovations Gmbh
SpainAll drugs from this manufacturer
-
It is used to treat and prevent bleeding in patients aged 12 years and older with hemophilia A (a hereditary disorder caused by a deficiency of factor VIII).
Dosage form: powder and solvent for solution for injection
Active substance Dosage rurioctocog alfa pegol 1000 UI -
It is used to treat and prevent bleeding in patients aged 12 years and older who suffer from hemophilia A (a hereditary disorder caused by a deficiency of factor VIII).
Dosage form: powder and solvent for solution for injection
Active substance Dosage rurioctocog alfa pegol 2000 UI -
It is used for the treatment and prevention of bleeding in patients aged 12 years and older with hemophilia A (a hereditary disorder caused by a deficiency of factor VIII).
Dosage form: powder and solvent for solution for injection
Active substance Dosage rurioctocog alfa pegol 500 UI -
It is used for the treatment and prevention of bleeding in patients aged 12 years and older with hemophilia A (a hereditary disorder caused by a deficiency of factor VIII).
Dosage form: powder and solvent for solution for injection
Active substance Dosage rurioctocog alfa pegol 3000 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia A or B who have an inhibitor. It is also used to prevent bleeding in non-hemophilic individuals with an acquired factor VIII inhibitor and for prophylaxis during surgical interventions in patients with hemophilia A with an inhibitor.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage antinhibitor coagulant complex 100 U/ml -
It is used to treat and prevent bleeding in patients with hemophilia A or B who have an inhibitor. It is also used to treat bleeding in non-hemophilic individuals with an acquired factor VIII inhibitor and to prevent bleeding during surgery in patients with hemophilia A and an inhibitor.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage antinhibitor coagulant complex 50 U -
It is used to treat people who do not have enough antibodies in their blood (such as in cases of immunodeficiencies, certain blood cancers, or transplants) and also to treat some inflammatory disorders such as Kawasaki disease, Guillain-Barré syndrome, or idiopathic thrombocytopenic purpura.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage normal human immunoglobulin 10 g -
It is used to treat patients who do not have enough antibodies in their blood (such as in cases of immunodeficiencies, certain blood cancers, or transplants) and to treat some inflammatory disorders such as Kawasaki disease, Guillain-Barré syndrome, or idiopathic thrombocytopenic purpura.
Dosage form: powder and solvent for solution for infusion
Active substance Dosage normal human immunoglobulin 5000 mg -
It is used for patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for adults, children, and adolescents with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used to treat patients with a weak immune system who do not have enough antibodies in the blood (primary or secondary immunodeficiencies) and for patients with chronic inflammatory demyelinating polyneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used in adults and children with a weak immune system who do not have enough antibodies to fight infections. It is also used in adults, children, and adolescents with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), an autoimmune disease that affects the nerves.
Dosage form: solution for infusion
Active substance Dosage normal human immunoglobulin 100 mg -
It is used for the treatment and prevention of bleeding in people with congenital hemophilia B, replacing the missing or malfunctioning blood coagulation factor IX.
Dosage form: powder and solvent for solution for injection and for infusion
Active substance Dosage factor ix 1200 UI -
It is used to treat hemorrhages, prevent bleeding before or after surgery, and to treat coagulation factor deficiency, whether due to congenital (from birth) or acquired causes.
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ii 375 - 708 UI factor vii 417 UI factor ix 500 UI factor x 500 UI human protein c ≥ 333 UI -
It is used to treat hemorrhages, prevent bleeding before or after surgery, and to treat coagulation factor deficiency (whether acquired due to medication or congenital).
Dosage form: powder and solvent for solution for injection
Active substance Dosage factor ii 480-900 UI factor vii 500 UI factor ix 600 UI factor x 600 UI protein c MIN 400 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (Christmas disease), a hereditary blood disorder caused by a deficiency of factor IX.
Dosage form: powder and solvent for injectable suspension
Active substance Dosage nonacog gamma 1000 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (Christmas disease), a hereditary blood disorder caused by a deficiency of factor IX.
Dosage form: powder and solvent for injectable suspension
Active substance Dosage nonacog gamma 2000 UI -
It is used for the treatment and prevention of bleeding in patients with hemophilia B (Christmas disease), a hereditary disorder caused by a deficiency of factor IX in the blood.
Dosage form: powder and solvent for injectable suspension
Active substance Dosage nonacog gamma 3000 UI